ClinicalMetric tracks all active clinical trials for adhd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — adhd Clinical Trials
How many clinical trials are currently recruiting for adhd?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for adhd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adhd?
adhd research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adhd clinical trial?
Eligibility criteria for adhd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07281092
Recruiting
Enrollment
36 pts
Location
United States
Sponsor
Seattle Children's Hospital
NCT07834437
Recruiting
Enrollment
120 pts
Location
Sweden
Sponsor
Region Stockholm
NCT06808425
Recruiting
Enrollment
200 pts
Location
Sweden
Sponsor
Halmstad University
NCT06298136
Recruiting
Enrollment
208 pts
Location
Hong Kong
Sponsor
The Hong Kong Polytechnic Univ...
NCT07001293
Recruiting
Enrollment
80 pts
Location
United States
Sponsor
University of Pittsburgh
NCT05299814
Recruiting
Enrollment
65 pts
Location
United States
Sponsor
Milton S. Hershey Medical Cent...
NCT06971640
Recruiting
Enrollment
250 pts
Location
United States
Sponsor
Duke University
NCT07566468
Recruiting
Enrollment
110 pts
Location
United States
Sponsor
National Institute of Mental H...
NCT07042347
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06823492
Recruiting
Enrollment
120 pts
Location
United Kingdom
Sponsor
University of Manchester
NCT03221244
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
University of California, Davi...
NCT07291453
Recruiting
Enrollment
250 pts
Location
Japan
Sponsor
Okinawa Institute of Science a...
NCT07900451
Recruiting
Enrollment
90 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT07595783
Recruiting
Enrollment
40 pts
Location
Germany
Sponsor
Bielefeld University
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology